MCK McKesson Corporation
$866.64
McKesson Corporation (MCK) is confirmed to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $10.72 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -5.0% since its last earnings release on August 5, 2026.
McKesson Beat Expectations, Raises Earnings Guidance, but Remains In-line with Estimates
Wednesday, August 5, 2026 · 4:10 PM ET
Earnings Date
2nd Quarter, Sep 2026
Nov 4
Wednesday · 4:10 PM ET
Earnings Whisper
-
vs $10.72
Rev est $110.14B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$882.92
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About McKesson Corporation
McKesson Corporation distributes pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs.
Sector
Healthcare
Industry
Drugs Wholesale
Held By 10 ETFs, by dollar flow
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- RTH VanEck Retail ETF
- RTH VanEck Retail ETF
- IYK iShares U.S. Consumer Staples ETF
- IYK iShares U.S. Consumer Staples ETF
- PPH VanEck Pharmaceutical ETF
- PPH VanEck Pharmaceutical ETF
Charts powered in part by Lightweight Charts™ by TradingView.